Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087943

Email this page to a colleague

« Back to Dashboard

NDA 087943 describes THEO-24, which is a drug marketed by Actient Pharms, Auxilium Pharms Inc, and Auxilium Pharms Llc, and is included in four NDAs. It is available from one supplier. Additional details are available on the THEO-24 profile page.

The generic ingredient in THEO-24 is theophylline. There are thirty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087943
Applicant:Auxilium Pharms Llc
Formulation / Manufacturing:see details
Pharmacology for NDA: 087943
Suppliers and Packaging for NDA: 087943
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943 ANDA Endo Pharmaceuticals, Inc. 52244-200 52244-200-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-200-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength200MG
Approval Date:Aug 22, 1983TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.